论文部分内容阅读
目的探讨对哮喘儿童规范治疗的疗效。方法随机分为管理组和对照组,两组均观察1年以上。管理组在医师指导下正确使用布地奈德福莫特罗粉吸入剂(信必可都保),进行哮喘管理教育,对照组不规则使用布地奈德福莫特罗粉吸入剂,无哮喘管理教育。结果两组疗效差异有显著性,管理组疗效优于对照组(P<0.0001),管理组临床控制率71.05%。年急诊率和年住院率管理组少于对照组。管理组用药1年无药物副反应。结论对哮喘儿童进行规范治疗可使患儿临床症状缓解,生活质量提高。
Objective To investigate the efficacy of standard treatment of children with asthma. Methods were randomly divided into management group and control group, both groups were observed for more than 1 year. The management team correctly administered budesonide formoterol powder inhalers (BDT) under the direction of physicians for asthma management education and the control group irregularly used budesonide formoterol powder inhalers without asthma management education. Results There was significant difference between two groups in curative effect, and the curative effect in the management group was better than that in the control group (P <0.0001). The clinical control rate in the management group was 71.05%. The annual emergency rate and annual hospitalization rate were less in the management group than in the control group. Management group medication for 1 year without drug side effects. Conclusions The standardized treatment of children with asthma can relieve clinical symptoms and improve the quality of life.